Group 4 is the most prevalent group comprising 43% of all medulloblastomas and can be subdivided into three subgroups: Group 4α, characterized by MYCN amplification; Group 4β by CNCAIP duplication and Group 4γ by CDK6 amplification [187]. Here, MYCN is linked to medulloblastoma.